1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
622ADCABFD00EF5476525813F003CA16B
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/22ADCABFD00EF5476525813F003CA16B!OpenDocument
18
19OpenDocument
203.233.242.204
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Clinical Operations Clinical Trial Management

Document Excerpt: Investigator Initiated Trials Management: Structure and Resource Allocation

DB Image

ID: MD-564


Features:

6 Info Graphics

26 Data Graphics

440+ Metrics

4 Narratives


Pages/Slides: 4


Published: 2017


Delivery Format: Online PDF Document


 

License Options:


Download FREE Excerpt

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
To download this excerpt, click "Download Free Excerpt".


To return to the study abstract to purchase the full study - click here

This excerpt includes research findings and metrics from document #5464 "Investigator Initiated Trials Management: Structure and Resource Allocation".


Industries Profiled:
Pharmaceutical; Biotech; Biopharmaceutical; Manufacturing; Consumer Products; Diagnostic; Medical Device; Health Care; Clinical Research; Laboratories


Companies Profiled:
Abbvie; Allergan; Alnylam Pharmaceuticals; Bayer; Boehringer Ingelheim; Cook Medical; Dexcom; Fresenius Medical Care; Fujirebio Diagnostics; Galderma; Grifols; Horizon Pharma; Kyowa Kirin; Medtronic; Merck; Pfizer; Pharmacyclics; Sanofi; Santen; Shire; Smith & Nephew; UCB Pharma; Vifor Pharma

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.